Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Journal of Hepatology, 2(65), p. 280-288, 2016

DOI: 10.1016/j.jhep.2016.02.043

Links

Tools

Export citation

Search in Google Scholar

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study

Journal article published in 2016 by Michael Bitzer ORCID, Marius Horger, Edoardo G. Giannini, Tom M. Ganten, Marcus A. Wörns, Jens T. Siveke, Matthias M. Dollinger, Guido Gerken, Max E. Scheulen, Henning Wege, Vittorina Zagonel, Umberto Cillo, Franco Trevisani, Armando Santoro ORCID, Vincenzo Montesarchio and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO